Arbutus Biopharma Corporation盘中异动股价大跌5.26%

市场透视2025-05-15

北京时间2025年05月15日21时34分，Arbutus Biopharma Corporation（ABUS.us）股票出现波动，股价大幅下跌5.26%。截至发稿，该股报2.99美元/股，成交量11.2639万股，换手率0.06%，振幅4.27%。最近的财报数据显示，该股实现营业收入1.76百万美元，净利润-24.53百万美元，每股收益-0.13美元，毛利--，市盈率-7.47倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535826623?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-15 21:34","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535826623","market":"us","top_or_hot":-1,"title":"Arbutus Biopharma Corporation盘中异动 股价大跌5.26%","media":"市场透视","content":"<div>\n<p>北京时间2025年05月15日21时34分，Arbutus Biopharma Corporation（ABUS.us）股票出现波动，股价大幅下跌5.26%。截至发稿，该股报2.99美元/股，成交量11.2639万股，换手率0.06%，振幅4.27%。最近的财报数据显示，该股实现营业收入1.76百万美元，净利润-24.53百万美元，每股收益-0.13美元，毛利--，市盈率-7.47倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213405a47fa6e9&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Arbutus Biopharma Corporation盘中异动 股价大跌5.26%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArbutus Biopharma Corporation盘中异动 股价大跌5.26%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-15 21:34 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213405a47fa6e9&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月15日21时34分，Arbutus Biopharma Corporation（ABUS.us）股票出现波动，股价大幅下跌5.26%。截至发稿，该股报2.99美元/股，成交量11.2639万股，换手率0.06%，振幅4.27%。最近的财报数据显示，该股实现营业收入1.76百万美元，净利润-24.53百万美元，每股收益-0.13美元，毛利--，市盈率-7.47倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213405a47fa6e9&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ABUS","symbol_name":"Arbutus Biopharma Corporation","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213405a47fa6e9&s=b","article_id":"2535826623","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213405a47fa6e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535826623","pubTimestamp":1747316045,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月15日21时34分，Arbutus Biopharma Corporation股票出现波动，股价大幅下跌5.26%。截至发稿，该股报2.99美元/股，成交量11.2639万股，换手率0.06%，振幅4.27%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Nucana Plc、Abpro Holdings, Inc、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为6822.75%、1870.39%、272.81%，振幅较大的相关个股有Nucana Plc、Pasithea Therapeutics Corp.、Onconetix, Inc.，振幅分别为35.84%、20.55%、15.09%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家专注于传染病的临床阶段生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ABUS":"Arbutus Biopharma Corporation","BK4139":"生物科技"},"translate_title":"Arbutus Biopharma Corporation stock plunges 5.26% after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABUS":1},"content_text":"北京时间2025年05月15日21时34分，Arbutus Biopharma Corporation（ABUS.us）股票出现波动，股价大幅下跌5.26%。截至发稿，该股报2.99美元/股，成交量11.2639万股，换手率0.06%，振幅4.27%。最近的财报数据显示，该股实现营业收入1.76百万美元，净利润-24.53百万美元，每股收益-0.13美元，毛利--，市盈率-7.47倍。机构评级方面，在所有4家参与评级的机构中，75%的券商给予买入建议，25%的券商给予持有建议，无券商给予卖出建议。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Nucana Plc、Abpro Holdings, Inc、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为6822.75%、1870.39%、272.81%，振幅较大的相关个股有Nucana Plc、Pasithea Therapeutics Corp.、Onconetix, Inc.，振幅分别为35.84%、20.55%、15.09%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家专注于传染病的临床阶段生物制药公司。该公司正在利用其广泛的病毒学专业知识来识别和开发具有不同作用机制的新型疗法，这些疗法可以结合起来为慢性乙型肝炎病毒 （cHBV） 患者提供功能性治愈。其内部开发的专有化合物管道包括 RNAi 治疗药物 imdusiran （AB-729） 和口服 PD-L1 抑制剂 AB-101。此外，该公司还专注于最大限度地利用其内部开发的脂质纳米颗粒 （LNP） 递送技术的机会。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535826623","isCrawlerRequest":true}

Arbutus Biopharma Corporation盘中异动 股价大跌5.26%

精彩评论

Arbutus Biopharma Corporation盘中异动股价大跌5.26%